2020, Number 4
<< Back Next >>
Rev Nefrol Dial Traspl 2020; 40 (4)
The Covid-19 Pandemic and the Kidney, Guayas, Ecuador
Coello RD, Salgado W, Pazmiño GBJ, Vazquez V, Veron D
Language: Spanish
References: 27
Page: 279-282
PDF size: 188.26 Kb.
Text Extraction
No abstract.
REFERENCES
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al.Clinical features of patients infected with 2019 novelcoronavirus in Wuhan, China [published correctionappears in Lancet. 2020;395(10223):496.]. Lancet. 2020;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5.
Ecuador. Dirección General de Registro Civil,Identificacion y Cedulación. Cifras defunciones,provincias/cantones. Registro civil del 12 de marzo al22 de abril de 2020 [Internet]. Disponible en: (consulta: 15/05/2020).
Bernard S, Blood D, Burn-Murdoch J, Harlow M,Nevitt C, Smith A, et al. Coronavirus tracked: thelatest figures as countries start to reopen [Internet].Financial Times, july 19 2020. Disponible en: (consulta: 15/05/2020).
Navarro JC, Arrivillaga-Henríquez J, Salazar-Loor J,Rodríguez-Morales AJ. COVID-19 and dengue, coepidemicsin Ecuador and other countries in LatinAmerica: Pushing strained health care systems overthe edge. Travel Med Infect Dis. 2020;101656. doi:10.1016/j.tmaid.2020.101656.
Chao JY, Derespina KR, Herold BC, Goldman DL,Aldrich M, Weingarten J, et al. Clinical characteristicsand outcomes of hospitalized and critically ill childrenand adolescents with coronavirus disease 2019(COVID-19) at a Tertiary Care Medical Center in NewYork City. J Pediatr. 2020;S0022-3476(20)30580-1.doi: 10.1016/j.jpeds.2020.05.006.
Cheng Y, Luo R, Wang K, Zhang M, Wang Z,Dong L, et al. Kidney disease is associated with inhospitaldeath of patients with COVID-19. Kidney Int.2020;97(5):829-38. doi: 10.1016/j.kint.2020.03.005.
Richardson S, Hirsch JS, Narasimhan M, Crawford JM,McGinn T, Davidson KW. Presenting characteristics,comorbidities, and outcomes among 5700 patientshospitalized with COVID-19 in the New York Cityarea. JAMA. 2020;323(20):2052-9. doi: 10.1001/jama.2020.6775.
Rodríguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y,Escalera-Antezana JP, et al. Clinical, laboratory andimaging features of COVID-19: a systematic review andmeta-analysis. Travel Med Infect Dis. 2020;34:101623.doi: 10.1016/j.tmaid.2020.101623.
Perico L, Benigni A, Remuzzi G. Should COVID-19concern nephrologists? Why and to what extent? Theemerging impasse of angiotensin blockade. Nephron.2020;144:213-21. doi: 10.1159/000507305.
Ronco C, Reis T. Kidney involvement in COVID-19and rationale for extracorporeal therapies. Nat RevNephrol. 2020;16(6):308-10. doi: 10.1038/s41581-020-0284-7.
Sise ME, Baggett MV, Shepard JO, Stevens JS, Rhee EP.Case 17-2020: a 68-year-old man with COVID-19 andacute kidney injury. N Engl J Med. 2020;382(22):2147-56. doi: 10.1056/NEJMcpc2002418.
Varga Z, Flammer AJ, Steiger P, Haberecker M,Andermatt R, Zinkernagel AS, et al. Endothelial cellinfection and endotheliitis in COVID-19. Lancet.2020;395(10234):1417-8. doi: 10.1016/S0140-6736(20)30937-5.
Su H, Yang M, Wan C, Yi L, Tang F, Zhu H, et al.Renal histopathological analysis of 26 postmortemfindings of patients with COVID-19 in China.Kidney Int. 2020;98(1):219-27. doi: 10.1016/j.kint.2020.04.003.
Larsen CP, Bourne TD, Wilson JD, Saqqa O,Sharshir MA. Collapsing glomerulopathy in a patientwith COVID-19. Kidney Int Rep. 2020;5(6):935-9. doi:10.1016/j.ekir.2020.04.002.
Nasr SH, Kopp JB. COVID-19-associated collapsingglomerulopathy: an emerging entity. Kidney Int Rep.2020;5(6):759-61. doi: 10.1016/j.ekir.2020.04.030.
Jarcho JA, Ingelfinger JR, Hamel MB, D’Agostino RB,Harrington DS. Inhibitors of the renin-angiotensinaldosteronesystem and COVID-19. N Engl J Med.2020;382:2462-4. doi: 10.1056/NEJMe2012924.
Lely AT, Hamming I, van Goor H, Navis GJ. RenalACE2 expression in human kidney disease. J Pathol.2004;204(5):587-93. doi: 10.1002/path.1670.
Hirsch JS, Ng JH, Ross DW, Sharma P, ShahHH, Barnett RL, et al. Acute kidney injury inpatients hospitalized with COVID-19. Kidney Int.2020;98(1):209-18. doi: 10.1016/j.kint.2020.05.006.
Rismanbaf A, Zarei S. Liver and kidney injuries inCOVID-19 and their effects on drug therapy; a letterto Editor. Arch Acad Emerg Med 2020;8(1):e17.
Li J, Xu G. Lessons from the experience inWuhan to reduce risk of COVID-19 infection inpatients undergoing long-term hemodialysis. ClinJ Am Soc Nephrol. 2020;15(5):717-9. Doi: 10.2215/CJN.03420320.
Fu D, Yang B, Xu J, Mao Z, Zhou C, Xue C.COVID-19 infection in a patient with end-stagekidney disease. Nephron. 2020;144(5):245-7. doi:10.1159/000507261.
Sánchez-Álvarez JE, Pérez Fontán M, Jiménez MartínC, Blasco Pelícano M, Cabezas Reina CJ, SevillanoPrieto AM, et al. Situación de la infección por SARSCoV-2 en pacientes en tratamiento renal sustitutivo.Informe del Registro COVID-19 de la SociedadEspañola de Nefrología (SEN). Nefrología (Madr.)2020;40(3):272-8. doi: 10.1016/j.nefro.2020.04.002.
Alberici F, Delbarba E, Manenti C, Econimo L,Valerio F, Pola A, Brescia Renal COVID Task Force,et al. Management of patients on dialysis and withkidney transplantation during the SARS-CoV-2(COVID-19) pandemic in Brescia, Italy. Kidney IntRep. 2020;5(5):580-5. doi: 10.1016/j.ekir.2020.04.001.
Zhang H, Chen Y, Yuan Q, Xia QX, Zeng XP, Peng JT,et al. Identification of kidney transplant recipients withCoronavirus disease 2019. Eur Urol. 2020;77(6):742-7.doi: 10.1016/j.eururo.2020.03.030.
Columbia University Kidney Transplant Program.Early description of Coronavirus 2019 disease in kidneytransplant recipients in New York. J Am Soc Nephrol.2020;31(6):1150-6. doi: 10.1681/ASN.2020030375.
Akalin E, Azzi Y, Bartash R, Seethamraju H,Parides M, Hemmige V, et al. Covid-19 and kidneytransplantation. N Engl J Med. 2020;382(25):2475-7.doi: 10.1056/NEJMc2011117.
Agarwal A, Zoccali C, Vivekanand J. Ensuringoptimal care for people with kidney diseases duringthe COVID-19 pandemic [Internet]. Disponibleen: (consulta:15/05/2020).